(Q41454086)

English

Antisense oligonucleotides as therapeutics for malignant diseases.

scientific article published on April 1997

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

9129689

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9129689%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

review article

1 reference

stated in

Europe PubMed Central

title

Antisense oligonucleotides as therapeutics for malignant diseases (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

9129689

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9129689%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

author name string

Ho PT

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

9129689

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9129689%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

Parkinson DR

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

9129689

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9129689%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

publication date

1 April 1997

1 reference

stated in

Europe PubMed Central

PubMed ID

9129689

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9129689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

PubMed ID

9129689

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9129689%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

volume

24

1 reference

stated in

Europe PubMed Central

PubMed ID

9129689

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9129689%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

page(s)

187-202

1 reference

stated in

Europe PubMed Central

PubMed ID

9129689

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9129689%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed ID

9129689

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9129689%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 November 2019

Identifiers

PubMed ID

9129689

1 reference

stated in

Europe PubMed Central

PubMed ID

9129689

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9129689%20AND%20SRC:MED&resulttype=core&format=json

(Q41454086)

Antisense oligonucleotides as therapeutics for malignant diseases.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)